skip to Main Content

CNOGA Medical Announces the Glucometer-Combo, TensorTip VSM and HXM at Event in Thailand

TI’s DSP technologies enable high-performance, low-power solutions

OR AKIVA, Israel – January 24, 2012 – CNOGA Medical, the leading provider of revolutionary non-invasive/touch-free medical monitoring devices, today introduced three new devices into its medical monitoring family: the Glucometer-Combo, TensorTip Vital Signs Monitor (VSM) and Hemoglobin Monitor (HXM).

The Glucometer-Combo, VSM and HXM were developed by CNOGA working closely with Texas Instruments Incorporated (TI) as the key component supplier. By introducing this revolutionary product line, CNOGA provides a long sought after alternative to the pain, inconvenience, cost and embarrassment diabetic individuals experience every day (often many times a day) with current glucose monitoring. CNOGA provides an non-invasive device that allows pain-free monitoring of blood glucose levels in tissue capillaries (finger) device. This solution is a first of its kind to be commercialized.

The TensorTip VSM can perform this measurement by utilizing the waveforms needed for accuracy and continuous monitoring. The TensorTip VSM output information includes continuous blood pressure monitoring, continuous oxygen saturation (SpO2) monitoring, pulse monitoring, continuous blood pressure waveform where the stroke volume can be determined, continuous fingertip electrocardiogram and peripheral pulse waveform. The VSM device has CE Clearance.

CNOGA’s HXM uses breakthrough technology enabling non-invasive monitoring of SpO2, pulse per minute (PPM) and hemoglobin rate in the finger tissue capillaries.  In addition, it shows the capillary pulse waveform and hemoglobin rate variation during the monitoring period.  Results are stored in the device memory for history review.

TI’s high-performance DSP, efficient analog signal chain and power management technologies enable the ultra-low power, innovative and compact products.

CNOGA’s Glucometer-Combo, HXM and VSM will be presented to Thailand’s local media, medical distributors and the Diabetes Association of Thailand on the 25th of January 2012. Thailand’s hospitals and medial clinics have won international acclaim and recognition for their outstanding state-of-the-art facilities, service and highly-qualified medical practitioners. Thailand’s medical sector serves over 1.5 million medical tourists from all over the world annually.

“CNOGA and TI have been working together on concept approval since February 2006. What we announce today is the result of the collaboration between TI and CNOGA and the initial support received from the BIRD Foundation and the USA-Israel bilateral foundation supporting joint venture development. CNOGA is very pleased to select TI processors not only because they enable the best performance, but because TI shares our vision to create revolutionary medical monitoring devices. TI has supported CNOGA and provided international assistance every step of the way,”said Larry SusmanVice President, Sales and Marketing, CNOGA.

“TI is excited to work with CNOGA and see these new, revolutionary medical solutions go to market for their customers,” said Kim Devlin-Allen, business unit manager, DaVincivideo communications products, TI. “We’re proud that our DSP processors were selected to provide real-time, accurate analysis of patient information in CNOGA’s state-of-the-art medical devices.”

For more information, please contact:

Larry Susman,VP Sales and Marketing

 

larry@cnoga.com
Tel:  +972-4-6361080

 

About CNOGA

With the state of the art technology, CNOGA Medical provides a patent pending and revolutionary solution for the non-invasive / touch-free medical monitoring devices. This breakthrough technology makes a huge leap in the non-invasive medical devices world enabling for a non invasive device an ongoing, real time monitoring of physiological parameters like: capillary blood sugar, heartbeat rate, blood pressure, SpO2, capillary pH, Hematocrit, Hemoglobin, RBC count, stroke volume, stroke volume variation and CO2 capillary concentration.

Leave a Reply

Back To Top